Blog Detail
NLNG Backs AI Innovation That Could Cut MRI Scan Time by 90%

NaijaTalk

|

2026-10-06

NLNG Backs AI Innovation That Could Cut MRI Scan Time by 90%

Nigeria LNG Limited has presented GenScan AI, an artificial intelligence-powered medical imaging technology developed by Nigerian researcher Mary-Brenda Akoda, with the potential to reduce Magnetic Resonance Imaging scan times by up to 90 per cent. The innovation was presented to health professionals, scientists, policymakers and other stakeholders in Abuja on Monday as part of efforts to explore how the technology could move from research into practical clinical use. GenScan AI emerged as the winning entry of the 2026 Nigeria Prize for Science and Innovation, sponsored by NLNG.
 GenScan AI uses an artificial intelligence algorithm known as C-MORE to reconstruct MRI images from substantially less acquired data. According to information presented by the prize organisers, the technology could reduce MRI acquisition time by up to 90 per cent without requiring hospitals to purchase new MRI hardware.  Akoda explained that the technology could reduce a 20-minute MRI examination to about two minutes and a one-hour scan to approximately six minutes.
She said the system is designed to work with existing compatible MRI machines, potentially allowing hospitals and diagnostic centres to examine more patients with the equipment they already have.  The researcher said long MRI examinations can be particularly difficult for patients who are elderly, in pain, anxious or unable to remain still for extended periods. Patient movement can blur images and sometimes lead to repeated scans or the need for sedation, increasing both the burden on patients and the pressure on healthcare facilities.
 Akoda said her motivation for developing the technology was linked to a personal experience involving an elderly loved one who suffered a stroke and needed an urgent MRI examination. She said the patient faced a long waiting period before the required scan could be obtained, and the person's condition deteriorated before the diagnosis could be completed.  Rather than requiring hospitals to invest in additional expensive MRI machines, GenScan AI is intended to improve the efficiency of existing equipment by using AI to reconstruct diagnostic-quality images from a smaller amount of acquired data.
This could potentially increase scanner capacity, shorten waiting lists and allow more patients to receive diagnostic examinations.  Akoda reported that the technology achieved up to 99.7 per cent similarity to conventional MRI images. She also said a blinded assessment by a consultant radiologist at Buckinghamshire NHS Hospital in the United Kingdom found the GenScan AI images diagnostically equivalent to conventional images in the cases assessed.
These findings still need to be considered alongside further clinical testing and regulatory evaluation before widespread clinical deployment.  The technology has also undergone research and development supported by organisations including Innovate UK, UK Research and Innovation and the NHS Clinical Entrepreneur Programme. Akoda said clinical partners have been secured in the United Kingdom, United States, Kenya and Nigeria, while a Nigerian diagnostic centre is supporting a planned clinical pilot.
 The next stage for GenScan AI involves regulatory submission and clinical trials. Akoda said commercial deployment is targeted for the second half of 2027, meaning the technology is not yet a generally available replacement for conventional MRI scanning. Its reported benefits will need to be confirmed through the required clinical and regulatory processes.
 At the Abuja presentation, NLNG's General Manager for External Relations and Sustainable Development, Dr Sophia Horsfall, said the company's interest extended beyond recognising scientific achievement to ensuring that research could produce practical improvements in people's lives. She said faster medical imaging could help healthcare providers make better use of existing equipment. Professor Barth Nnaji, Chairman of the Nigeria Prize for Science and Innovation Advisory Board, said GenScan AI stood out because of its scientific strength and its potential to address a practical healthcare challenge.
He stressed that further engagement with clinicians and other stakeholders would be necessary to determine how the technology could be safely and effectively applied.  Akoda emerged as the winner from a record 237 entries submitted for the 2026 Nigeria Prize for Science and Innovation under the theme, “Innovations in Artificial Intelligence, ICT and Digital Technologies for Development.” Her selection followed an independent evaluation by a panel of judges chaired by former Minister of Communications Dr Omobola Johnson and subsequent endorsement by the prize's Advisory Board. Her victory also makes her the first woman and first millennial to win the Nigeria Prize for Science and Innovation as an individual recipient.
She is scheduled to receive the US$100,000 prize at the Grand Award Night on October 9, 2026. The Federal Government has also indicated its willingness to support the innovation. Minister of Education Dr Tunji Alausa said his ministry would help connect Akoda with federal teaching hospitals and Federal Medical Centres for planned Nigerian pilot programmes.
He also called for the involvement of the Ministry of Health as the technology moves toward clinical deployment.
reference: https://punchng.com/nlng-unveils-ai-tool-to-cut-mri-scan-time/

Subscribe To Get Updates on Our Latest Blog Post

No credit card required

0 Comments

No comments yet.

Leave Your Comment

You may also like

No related posts available